Inside the research

Prestige Consumer Healthcare Inc.

PBH Research profile · latest available data

Price overview

$46.61

▲ +0.96 (+2.1%)

52w hi$70.21
52w lo$44.97
Vol467.70K
As of25 Sep 2026

The Verdict

Hold

Our score -0.24

Short-0.38
Medium-0.17
Long-0.11

computed 2026-09-27

Key fundamentals

Prestige Consumer Healthcare Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

Market cap$2.21B
Enterprise value$4.19B
Trailing P/E13.06x
Forward P/E9.17x
EV / EBITDA12.87x
P / S (ttm)2.00x
Profit margin15.6%
Return on equity9.1%
Revenue growth+6.5%
Earnings growth-35.8%
Debt / equity107.86

Layer Breakdown

LayerRawContribution
Fundamental+0.14
Sector+0.08
Technical-0.28
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.

United States · www.prestigebrands.com

Risk Metrics

Beta vs SPX0.39
Corr SPX0.20
Annual vol30.4%
Annual ret-17.8%
Sharpe-0.59
Max DD-49.5%

Window: 504 trading days (504 obs)

Material Events

DateEvent8-K
2026-08-14Officer / Director Changeread
2026-08-06Earnings Release, Reg FD Disclosure…read
2026-07-15Material Agreement, Material Obligation…read
2026-07-06Material Agreement, Material Obligation…read
2026-06-16Material Agreement, Acquisition / Disposition…read
2026-05-13Material Agreement, Earnings Release…read
2026-03-20Material Agreement, Reg FD Disclosure…read
2026-02-05Earnings Release, Reg FD Disclosure…read
2025-11-06Earnings Release, Reg FD Disclosure…read
2025-08-07Material Agreement, Earnings Release…read
2025-05-08Earnings Release, Reg FD Disclosure…read
2025-02-06Earnings Release, Reg FD Disclosure…read

SEC Filings

DateFormDoc
2026-08-148-Kview
2026-08-068-Kview
2026-08-0610-Qview
2026-08-054view
2026-08-054view
2026-08-054view
2026-08-054view
2026-08-054view
2026-07-158-Kview
2026-07-098-K/Aview
2026-07-068-Kview
2026-06-308-K/Aview
2026-06-29DEF 14Aview
2026-06-29ARSview
2026-06-168-Kview

The Long Run

FY 2011–2026 · 15 years

LineLatestCAGRTrend
Revenue$1.13B+9.0%
Gross profit$624.45M+10.5%
Operating income$309.41M+8.2%
Net income$209.34M+17.8%
Cash from ops$257.63M+10.0%

Indices

S&P SmallCap 600

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$45.34$46.72$44.97$46.61467.70K
Sep 24$46.12$46.49$45.30$45.65627.20K
Sep 23$47.45$47.46$45.91$45.92503.90K
Sep 22$47.55$47.80$47.02$47.73619.60K
Sep 21$45.01$47.00$44.46$46.80660.40K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →